Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Klein, M; Rosen, A; Lahousen, M; Graf, A; Vavra, N; Pakisch, B; Poschauko, J; Beck, A; Kucera, H.
Evaluation of adjuvant therapy after surgery for primary carcinoma of the fallopian tube.
Arch Gynecol Obstet. 1994; 255(1):19-24 Doi: 10.1007/BF02390670
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Lahousen Manfred
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
OBJECTIVE: To evaluate the impact of postoperative therapy (chemotherapy vs. irradiation) on overall survival. DESIGN: A nationwide retrospective analysis. SETTING: Hanusch-Krankenhaus, Department of Gynaecology, SUBJECTS: 115 patients with histologically proved primary carcinoma of the Fallopian tube: 49 received six treatment cycles of a cis-platinum regimen (group I), 24 patients were treated by full irradiation using 50 Gray minimum (group II). The two groups had a similar distribution of stage I and II; in the more advanced stages chemotherapy was the predominant method of treatment. RESULTS: The five-year survival rate was 53% for women receiving irradiation as against 27% for those given cis-platinum. If the analysis was restricted to those patients with comparable stage I and stage II lesions, the p-value (0.07) was of borderline significance. There was no advantage in adding abdominal to pelvic irradiation (P = 0.62). CONCLUSIONS: Stage I and stage II carcinoma is probably better treated postoperatively by radiotherapy than chemotherapy. Chemotherapy may have more therapeutic potential in patients with more advanced lesions.
Find related publications in this database (using NLM MeSH Indexing)
Adult -
Aged -
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Carcinoma - drug therapy
Chemotherapy, Adjuvant - drug therapy
Cisplatin - administration and dosage
Combined Modality Therapy - administration and dosage
Fallopian Tube Neoplasms - drug therapy
Female - drug therapy
Follow-Up Studies - drug therapy
Humans - drug therapy
Middle Aged - drug therapy
Neoplasm Staging - drug therapy
Radiotherapy Dosage - drug therapy
Retrospective Studies - drug therapy
Survival Analysis - drug therapy
Survival Rate - drug therapy

Find related publications in this database (Keywords)
Primary Carcinoma of the Fallopian Tube
Adjuvant Therapy
© Med Uni Graz Impressum